Home LiteratureArticle Details
PMID: 9511935 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR).

Journal of bioenergetics and biomembranes ·Vol. 29 ·No. 5 ·1997-10-00 ·Pages 503-24

Bianchet MA, Ko YH, Amzel LM, Pedersen PL

Abstract

Members of the ABC transporter superfamily contain two nucleotide binding domains. To date, the three dimensional structure of no member of this super-family has been elucidated. To gain structural insight, the known structures of several other nucleotides binding proteins can be used as a framework for modeling these domains. We have modeled both nucleotide binding domains of the protein CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) using the two similar domains of mitochondrial F1-ATPase. The models obtained, provide useful insights into the putative functions of these domains and their possible interaction as well as a rationale for the basis of Cystic Fibrosis causing mutations. First, the two nucleotide binding domains (folds) of CFTR are each predicted to span a 240-250 amino acid sequence rather than the 150-160 amino acid sequence originally proposed. Second, the first nucleotide binding fold, is predicted to catalyze significant rates of ATP hydrolysis as a catalytic base (E504) resides near the y phosphate of ATP. This prediction has been verified experimentally [Ko, Y.H., and Pedersen, P.L. (1995) J. Biol. Chem. 268, 24330-24338], providing support for the model. In contrast, the second nucleotide binding fold is predicted at best to be a weak ATPase as the glutamic acid residue is replaced with a glutamine. Third, F508, which when deleted causes approximately 70% of all cases of cystic fibrosis, is predicted to lie in a cleft near the nucleotide binding pocket. All other disease causing mutations within the two nucleotide binding domains of CFTR either reside near the Walker A and Walker B consensus motifs in the heart of the nucleotide binding pocket, or in the C motif which lies outside but near the nucleotide binding pocket. Finally, the two nucleotide binding domains of CFTR are predicted to interact, and in one of the two predicted orientations, F508 resides near the interface. This is the first report where both nucleotide binding domains of an ABC transporter and their putative domain-domain interactions have been modeled in three dimensions. The methods and the template used in this work can be used to analyze the structures and function of the nucleotide binding domains of all other members of the ABC transporter super-family.

MeSH Terms
ATP-Binding Cassette Transporters/chemistry Amino Acid Sequence Cystic Fibrosis Transmembrane Conductance Regulator/chemistry Humans Models, Molecular Molecular Sequence Data Proton-Translocating ATPases/chemistry Rec A Recombinases/chemistry
Chemicals
ATP-Binding Cassette Transporters CFTR protein, human Cystic Fibrosis Transmembrane Conductance Regulator Rec A Recombinases Proton-Translocating ATPases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bianchet M A
Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University, School of Medicine, Baltimore, MD 21205-2185, USA.
Ko Y H
Amzel L M
Pedersen P L
References (37)
37 references, click to expand
  1. ATP synthases. Structure, reaction center, mechanism, and regulation of one of nature's most unique machines.
    J Biol Chem. 1993 May 15;268(14):9937-40 PMID: 8486720
  2. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Nature. 1991 Dec 19-26;354(6354):526-8 PMID: 1722027
  3. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
    J Biol Chem. 1995 Jan 27;270(4):1711-7 PMID: 7530246
  4. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
    Proteins. 1991;11(4):281-96 PMID: 1758883
  5. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
    Science. 1989 Sep 8;245(4922):1066-73 PMID: 2475911
  6. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.
    Cell. 1991 Sep 6;66(5):1027-36 PMID: 1716180
  7. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.
    EMBO J. 1982;1(8):945-51 PMID: 6329717
  8. The spectrum of cystic fibrosis mutations.
    Trends Genet. 1992 Nov;8(11):392-8 PMID: 1279852
  9. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis.
    EMBO J. 1990 Aug;9(8):2351-9 PMID: 2196171
  10. The structure of the E. coli recA protein monomer and polymer.
    Nature. 1992 Jan 23;355(6358):318-25 PMID: 1731246
  11. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.
    Nature. 1990 Sep 27;347(6291):358-63 PMID: 1699126
  12. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
    Cell. 1993 Apr 23;73(2):335-46 PMID: 7682896
  13. The predicted secondary structures of the nucleotide-binding sites of six cation-transporting ATPases lead to a probable tertiary fold.
    Eur J Biochem. 1989 Jan 15;179(1):241-8 PMID: 2521827
  14. Catalytic mechanism of F1-ATPase.
    Biochim Biophys Acta. 1997 Mar 28;1319(1):19-58 PMID: 9107315
  15. Chemical and biological evolution of nucleotide-binding protein.
    Nature. 1974 Jul 19;250(463):194-9 PMID: 4368490
  16. The crystal structure of the nucleotide-free alpha 3 beta 3 subcomplex of F1-ATPase from the thermophilic Bacillus PS3 is a symmetric trimer.
    Structure. 1997 Jun 15;5(6):825-36 PMID: 9261073
  17. Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway.
    J Biol Chem. 1996 Mar 29;271(13):7261-4 PMID: 8631737
  18. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria.
    Nature. 1994 Aug 25;370(6491):621-8 PMID: 8065448
  19. Structural and functional similarities between the nucleotide-binding domains of CFTR and GTP-binding proteins.
    Biophys J. 1995 Dec;69(6):2443-8 PMID: 8599650
  20. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.
    J Mol Graph. 1993 Jun;11(2):134-8, 127-8 PMID: 8347566
  21. PHD: predicting one-dimensional protein structure by profile-based neural networks.
    Methods Enzymol. 1996;266:525-39 PMID: 8743704
  22. The cystic fibrosis transmembrane conductance regulator. Nucleotide binding to a synthetic peptide segment from the second predicted nucleotide binding fold.
    J Biol Chem. 1994 May 20;269(20):14584-8 PMID: 7514174
  23. The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S.
    Nature. 1993 Dec 16;366(6456):654-63 PMID: 8259210
  24. The RecA hexamer is a structural homologue of ring helicases.
    Nat Struct Biol. 1997 Feb;4(2):101-4 PMID: 9033586
  25. ATPase activity of the cystic fibrosis transmembrane conductance regulator.
    J Biol Chem. 1996 Nov 8;271(45):28463-8 PMID: 8910473
  26. Three dimensional structure of adenyl kinase.
    Nature. 1974 Jul 12;250(462):120-3 PMID: 4367210
  27. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).
    N Engl J Med. 1990 Nov 29;323(22):1517-22 PMID: 2233932
  28. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance.
    Annu Rev Microbiol. 1993;47:291-319 PMID: 7504904
  29. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia.
    J Clin Invest. 1992 Jan;89(1):339-49 PMID: 1370301
  30. Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function.
    Biochemistry. 1997 Apr 22;36(16):5053-64 PMID: 9125527
  31. The P-loop--a common motif in ATP- and GTP-binding proteins.
    Trends Biochem Sci. 1990 Nov;15(11):430-4 PMID: 2126155
  32. Prediction of the secondary structure of proteins from their amino acid sequence.
    Adv Enzymol Relat Areas Mol Biol. 1978;47:45-148 PMID: 364941
  33. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein.
    J Biol Chem. 1993 Nov 15;268(32):24330-8 PMID: 7693699
  34. A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.
    FEBS Lett. 1997 May 5;407(3):303-8 PMID: 9175873
  35. Sequence homologies between nucleotide binding regions of CFTR and G-proteins suggest structural and functional similarities.
    FEBS Lett. 1995 Jun 12;366(2-3):87-91 PMID: 7540563
  36. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.
    Nature. 1990 Jul 26;346(6282):362-5 PMID: 1973824
  37. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.
    Cell. 1990 Nov 16;63(4):827-34 PMID: 1699669
Article Info
Journal
Journal of bioenergetics and biomembranes
Abbr.
J Bioenerg Biomembr
ISSN
0145-479X
Published
1997-10-00
Pages
503-24
Language
English
Region
United States
NLM ID
7701859
Subset
IM
Grants
NIGMS NIH HHS · GM25432 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com